Study sheds new light on asthma, COPD

In cells lining the airway, high levels of certain proteins have long been linked with the overproduction of mucus characteristic of diseases like asthma and COPD. New research from the School of Medicine provides clues to potentially counteract inappropriate mucus production.

Imai receives NIH grant for aging research

Shin-ichiro Imai, MD, PhD, professor of developmental biology and of medicine at Washington University School of Medicine in St. Louis, has received a five-year, $1.56 million grant from the National Institute on Aging of the National Institutes of Health (NIH) for research titled “eNAMPT-mediated Adipo-hypothalamic Communication for NAD+ Production and Aging.”
DuBois named Bander professor of medical ethics

DuBois named Bander professor of medical ethics

James M. DuBois, DSc, PhD, has been named the Steven J. Bander Professor of Medical Ethics and Professionalism at the School of Medicine. In his research, DuBois develops measures to assess outcomes of training programs in ethics and professionalism in medicine and conducts social science studies of patient and research participant attitudes.

Frieden receives NIH grant for Alzheimer’s research

Carl Frieden, PhD, professor of biochemistry and molecular biophysics at Washington University School of Medicine in St. Louis, has received a five-year, $1.56 million grant from the National Institute on Aging of the National Institutes of Health (NIH) for research titled “Alzheimer’s Disease: Defining the apoE-amyloid-beta interaction.”
Harder-to-abuse OxyContin doesn’t stop illicit use

Harder-to-abuse OxyContin doesn’t stop illicit use

A reformulation of OxyContin (left) that makes it less likely to be abused than the older formulation (right) has curtailed the drug’s illicit use. But researchers at the School of Medicine have found that a significant percentage still abuse the drug despite package labeling that emphasizes its abuse-deterrent properties. 
View More Stories